Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $526000.0.

  • PROCEPT BioRobotics' Asset Writedowns and Impairment rose 3989.36% to $526000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 5815.77%. This contributed to the annual value of $1.9 million for FY2024, which is 8904.52% up from last year.
  • PROCEPT BioRobotics' Asset Writedowns and Impairment amounted to $526000.0 in Q3 2025, which was up 3989.36% from $570000.0 recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Asset Writedowns and Impairment registered a high of $905000.0 during Q2 2024, and its lowest value of -$25000.0 during Q4 2022.
  • In the last 5 years, PROCEPT BioRobotics' Asset Writedowns and Impairment had a median value of $353000.0 in 2024 and averaged $373083.3.
  • In the last 5 years, PROCEPT BioRobotics' Asset Writedowns and Impairment tumbled by 12212.39% in 2022 and then soared by 56781.61% in 2023.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Asset Writedowns and Impairment stood at $113000.0 in 2021, then plummeted by 122.12% to -$25000.0 in 2022, then surged by 2424.0% to $581000.0 in 2023, then increased by 3.27% to $600000.0 in 2024, then decreased by 12.33% to $526000.0 in 2025.
  • Its Asset Writedowns and Impairment was $526000.0 in Q3 2025, compared to $570000.0 in Q2 2025 and $330000.0 in Q1 2025.